Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S. 
Dublin, Feb. 25, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/zmzmmz/artificial_tears) has announced the addition of the "Artificial Tears - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 68 companies including many key and niche players such as:
- Abbott Medical Optics Inc. (US)
- Allergan, Inc. (US)
- Akorn, Inc. (US)
- Bausch & Lomb Incorporated. (US)
- Johnson & Johnson (US)
- Novartis International AG (Switzerland)
- Alcon, Inc. (Switzerland)
- Santen Pharmaceuticals Co, Ltd. (Japan)
- Novagali Pharma S.A. (France)
Key Topics Covered:
1. Industry Overview
2. Noteworthy Market Trends
3. Dry Eye Syndrome
4. Product Overview
5. Product Launches/Approvals/ Introductions
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
Total Companies Profiled: 68 (including Divisions/Subsidiaries 74)
- The United States (25)
- Canada (3)
- Japan (4)
- Europe (22)
- - France (3)
- - Germany (3)
- - The United Kingdom (5)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (17)
- Africa (2)
- Middle-East (1)
For more information visit http://www.researchandmarkets.com/research/zmzmmz/artificial_tears
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Optical
